A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation

Cellular Signalling

Volumn 28, Issue 5, 2016, Pages 498-505

  DiRenzo, Daniel M ^a   Chaudhary, Mirnal A ^a   Shi, Xudong ^a   Franco, Sarah R ^a   Zent, Joshua ^a   Wang, Katie ^a   Guo, Lian Wang ^a   Kent, K Craig ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Proliferation; TGF Smad3; Vascular smooth muscle cells; Wnt catenin

Indexed keywords

BETA CATENIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT11 PROTEIN; WNT2 PROTEIN; WNT2B PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN; WNT9A PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTA; CAROTID ARTERY DISEASE; CYTOLOGY; GENETICS; METABOLISM; NEOINTIMA; PATHOLOGY; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE; WNT SIGNALING PATHWAY;

ANIMALS; AORTA; BETA CATENIN; CAROTID ARTERY DISEASES; CELL PROLIFERATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RATS, SPRAGUE-DAWLEY; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84959018450     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.02.011     Document Type: Article

References (43)

1. Goodney P.P., Beck A.W., Nagle J., Welch H.G., Zwolak R.M. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J. Vasc. Surg. 2009, 50:54-60.
2. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
3. Goldman S., Zadina K., Moritz T., Ovitt T., Sethi G., Copeland J.G., Thottapurathu L., Krasnicka B., Ellis N., Anderson R.J., Henderson W. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative study. J. Am. Coll. Cardiol. 2004, 44:2149-2156.
4. Inoue T., Croce K., Morooka T., Sakuma M., Node K., Simon D.I. Vascular inflammation and repair: implications for reendothelialization, restenosis, and stent thrombosis. JACC Cardiovasc. Interv. 2011, 4:1057-1066.
5. Edlin R.S., Tsai S., Yamanouchi D., Wang C., Liu B., Kent K.C. Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: potential role of Smad3 in regulation of SMC proliferation. J. Vasc. Surg. 2009, 49:1289-1295.
6. Tsai S., Hollenbeck S.T., Ryer E.J., Edlin R., Yamanouchi D., Kundi R., Wang C., Liu B., Kent K.C. TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H540-H549.
7. Seay U., Sedding D., Krick S., Hecker M., Seeger W., Eickelberg O. Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent. J. Pharmacol. Exp. Ther. 2005, 315:1005-1012.
8. Kundi R., Hollenbeck S.T., Yamanouchi D., Herman B.C., Edlin R., Ryer E.J., Wang C., Tsai S., Liu B., Kent K.C. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc. Res. 2009, 84:326-335.
9. Shi X., DiRenzo D., Guo L.W., Franco S.R., Wang B., Seedial S., Kent K.C. TGF-beta/Smad3 stimulates stem cell/developmental gene expression and vascular smooth muscle cell de-differentiation. PLoS One 2014, 9.
10. Si Y., Ren J., Wang P., Rateri D.L., Daugherty A., Shi X.D., Kent K.C., Liu B. Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model. Arterioscler. Thromb. Vasc. Biol. 2012, 32:943-954.
11. Shi X., Guo L.W., Seedial S.M., Si Y., Wang B., Takayama T., Suwanabol P.A., Ghosh S., DiRenzo D., Liu B., Kent K.C. TGF-beta/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. Cell Death Dis. 2014, 5.
12. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
13. Wang J., Wynshaw-Boris A. The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. Curr. Opin. Genet. Dev. 2004, 14:533-539.
14. Mill C., Monk B.A., Williams H., Simmonds S.J., Jeremy J.Y., Johnson J.L., George S.J. Wnt5a-induced Wnt1-inducible secreted protein-1 suppresses vascular smooth muscle cell apoptosis induced by oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2014, 34:2449-2456.
15. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., Taketo M.M., von Melchner H., Plate K.H., Gerhardt H., Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008, 183:409-417.
16. Tsaousi A., Williams H., Lyon C.A., Taylor V., Swain A., Johnson J.L., George S.J. Wnt4/beta-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ. Res. 2011, 108:427-436.
17. Zhou B., Liu Y., Kahn M., Ann D.K., Han A., Wang H., Nguyen C., Flodby P., Zhong Q., Krishnaveni M.S., Liebler J.M., Minoo P., Crandall E.D., Borok Z. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J. Biol. Chem. 2012, 287:7026-7038.
18. Clowes M.M., Lynch C.M., Miller A.D., Miller D.G., Osborne W.R., Clowes A.W. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J. Clin. Invest. 1994, 93:644-651.
19. Ryer E.J., Hom R.P., Sakakibara K., Nakayama K.I., Nakayama K., Faries P.L., Liu B., Kent K.C. PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:780-786.
20. Lu W., Lin C., Roberts M.J., Waud W.R., Piazza G.A., Li Y. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/beta-catenin pathway. PLoS One 2011, 6.
21. Arend R.C., Londono-Joshi A.I., Samant R.S., Li Y., Conner M., Hidalgo B., Alvarez R.D., Landen C.N., Straughn J.M., Buchsbaum D.J. Inhibition of Wnt/beta-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. Gynecol. Oncol. 2014, 134:112-120.
22. Gwak J., Hwang S.G., Park H.S., Choi S.R., Park S.H., Kim H., Ha N.C., Bae S.J., Han J.K., Kim D.E., Cho J.W., Oh S. Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation. Cell Res. 2012, 237-247.
23. Zhang M., Wang M., Tan X., Li T.F., Zhang Y.E., Chen D. Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J. Biol. Chem. 2010, 285:8703-8710.
24. Jian H., Shen X., Liu I., Semenov M., He X., Wang X.F. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006, 20:666-674.
25. Zhang P., Cai Y., Soofi A., Dressler G.R. Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J. Biol. Chem. 2012, 287:21290-21302.
26. Uysal-Onganer P. I.C.L. Department of Surgery and Cancer, London, UK, R.M. Kypta, I.C.L. Department of Surgery and Cancer, London, UK, C.f.C.R.i.B.C.b. Department of Cell biology and Stem Cells Unit, Bilbao, Spain, Wnt11 in 2011 - the regulation and function of a non-canonical Wnt. Acta Physiol. 2015, 204:52-64.
27. Toyama T., Lee H.C., Koga H., Wands J.R., Kim M. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol. Cancer Res. 2010, 8:254-265.
28. Kobayashi M., Huang C.L., Sonobe M., Kikuchi R., Ishikawa M., Kitamura J., Miyahara R., Menju T., Iwakiri S., Itoi K., Yasumizu R., Date H. Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients. Exp. Ther. Med. 2012, 3:952-958.
29. Wang H., Fan L., Xia X., Rao Y., Ma Q., Yang J., Lu Y., Wang C., Ma D., Huang X. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer. Int. J. Gynecol. Cancer 2012, 22:755-761.
30. Shojima K., Sato A., Hanaki H., Tsujimoto I., Nakamura M., Hattori K., Sato Y., Dohi K., Hirata M., Yamamoto H., Kikuchi A. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively. Sci. Report. 2015.
31. Matsumoto K., Miki R., Nakayama M., Tatsumi N., Yokouchi Y. Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. Dev. Biol. 2008, 319:234-247.
32. Cheon S.S., Wei Q., Gurung A., Youn A., Bright T., Poon R., Whetstone H., Guha A., Alman B.A. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing 2006.
33. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
34. Adachi K., Mirzadeh Z., Sakaguchi M., Yamashita T., Nikolcheva T., Gotoh Y., Peltz G., Gong L., Kawase T., Alvarez-Buylla A., Okano H., Sawamoto K. Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007, 25:2827-2836.
35. Zhong W., Oguljahan B., Xiao Y., Nelson J., Hernandez L., Garcia-Barrio M., Francis S.C. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of beta-catenin dynamics. Cell. Signal. 2014, 26:2765-2772.
36. Kim K.I., Cho H.J., Hahn J.Y., Kim T.Y., Park K.W., Koo B.K., Shin C.S., Kim C.H., Oh B.H., Lee M.M., Park Y.B., Kim H.S. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler. Thromb. Vasc. Biol. 2006, 26:91-98.
37. Nunes R.O., Schmidt M., Dueck G., Baarsma H., Halayko A.J., Kerstjens H.A., Meurs H., Gosens R. GSK-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L1110-L1118.
38. Sinnberg T., Menzel M., Ewerth D., Sauer B., Schwarz M., Schaller M., Garbe C., Schittek B. beta-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One 2011, 6.
39. Zeng G., Apte U., Cieply B., Singh S., Monga S.P. siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007, 9:951-959.
40. Chen C., Zhao M., Tian A., Zhang X., Yao Z., Ma X. Aberrant activation of Wnt/beta-catenin signaling drives proliferation of bone sarcoma cells. Oncotarget 2015, 6:17570-17583.
41. Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., Horn A., Kireva T., Beyer C., Zwerina J., Schneider H., Sadowski A., Riener M.O., MacDougald O.A., Distler O., Schett G., Distler J.H. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat. Commun. 2012, 3:735.
42. Terada Y., Nakashima O., Inoshita S., Kuwahara M., Sasaki S., Marumo F. TGF-[bgr]-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int. 1999, 56:1378-1390.
43. Pietenpol J.A., Holt J.T., Stein R.W., Moses H.L. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3758-3762.